Performance of the Aorfix endograft in severely angulated proximal necks in the PYTHAGORAS United States clinical trial Mahmoud B. Malas, MD, MHS, William D. Jordan, MD, Michol A. Cooper, MD, PhD, Umair Qazi, MD, MPH, Adam W. Beck, MD, Michael Belkin, MD, William Robinson, MD, Mark Fillinger, MD Journal of Vascular Surgery Volume 62, Issue 5, Pages 1108-1118 (November 2015) DOI: 10.1016/j.jvs.2015.05.042 Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Fig 1 Kaplan-Meier curves for the standard angled, highly angled, and severely angled populations for 2-year freedom from (A) sac expansion (number at risk: 0 months, 218; 1 month, 211; 6 months, 204; 12 months, 192; and 24 months, 161), (B) type I or III endoleak (number at risk: 0 months, 218; 1 month, 210; 6 months, 202; 12 months, 191; and 24 months, 161), and (C) stent migration (number at risk: 0 months, 218; 1 month, 211; 6 months, 204; 12 months, 192; and 24 months, 161). Journal of Vascular Surgery 2015 62, 1108-1118DOI: (10.1016/j.jvs.2015.05.042) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Fig 2 Change (CHG) in oversize percentage over time. Index oversize percentage vs change in oversize percentage at 3 years at (A) 1 mm above superior mesenteric artery (SMA) proximal to the graft, (B) 1 mm below distal renal artery within the proximal seal zone of the graft, and (C) 15 mm below the distal renal artery below the proximal seal zone of the graft. D, Overall changes in oversize percentage over time. Journal of Vascular Surgery 2015 62, 1108-1118DOI: (10.1016/j.jvs.2015.05.042) Copyright © 2015 Society for Vascular Surgery Terms and Conditions